Article
Mutation analysis of the EGFR gene and its downstream signaling pathway in thymic carcinoma patients from a Chinese Han population.
The clinical respiratory journal - 1 Feb 2018
Zhan Ping, Chen Xiao, Wu Xiao-Yuan, Hou Zhi-Bo, Qian Qian, Zhang Yu, Zou Jue, Zhang Yuan-Qing, Wan Ming-Yue, Wang Jian-Dong, Yu Li-Ke, Xie Hai-Yan
Abstract excerpt
INTRODUCTION: For thymic carcinoma (TC), which is a rare epithelial neoplasm of the thymus gland, median survival with current treatments is only 2 years. OBJECTIVES: Mutations in the epidermal growth factor receptor (EGFR) gene or its downstream effectors may cause constitutive activation that leads to cell proliferation and metastases. Thus, molecular profiling is essential for selecting TC patients who may...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
